Category: Pharmaceutical

Categories
Pharmaceutical

Helicobacter Pylori Non-Invasive Testing Market is a modest 3.9% during 2021-2026

Helicobacter Pylori infections, or H. Pylori, are the most common types of infections affecting the digestive tract. The infection is prevalent among half of the world’s population, who typically reside in unhygienic and poor sanitary conditions. It is the most common reason for dyspepsia, peptic ulcers and gastric adenocarcinoma.

In view of this, the demand for H. Pylori testing has increased, particularly non-invasive molecular techniques such as real-time PCR and Chemiluminescence Immunoassay (CLIA). The Helicobacter Pylori Non-Invasive Testing market is anticipated to register a moderate CAGR of 3.9% during the forecast period (2020-2026).

Request a report sample to gain comprehensive insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=4774

Key Takeaways of Global H. Pylori Non-Invasive Testing Market Study:
  • By test type, the urea breath test segment is anticipated to hold a major chunk of the market, amounting to over two-fifth. High rate of accuracy in detecting the presence of H. Pylori and usefulness in evaluating post-treatment status are poised to leverage this segment.
  • The Stool Antigen Test segment shall comprise the 2nd largest share of the global H. Pylori Non-invasive testing market, accounting for over 40%. Simplicity and accuracy of the test in determining infection is anticipated to drive the segment’s growth.
  • By test method, the Laboratory-based Tests segment shall generate high demand. The ability to test a large number of patients and their accurate and precise methodologies are anticipated to be the key drivers. The segment is foreseen to hold more than three-fifth of the market.
  • By end-use, diagnostic labs are anticipated to be the most lucrative, capturing almost half of the total market. Key pharmaceutical companies partnering to provide wider reach for testing H. Pylori are anticipated to drive the market. For instance, in 2010, Meridian Bioscience entered into an agreement with DiaSorin S.p.A to develop infectious disease tests for use on its LIAISON automated instrumets.
  • North America is anticipated to be the most promising market. This is attributed to changing healthcare reforms. These reforms have directed organizations to abandon serology tests due to its uncertainty in predicting infections and to switch to urea-based and stool antigen testing. The region is anticipated to hold 31.1% of the H. Pylori testing market.
  • Asia-Pacific shows modest growth opportunities, owing to increased awareness about H. Pylori infections and government efforts to contain the risk of infections. Moreover, H. Pylori testing among communities with gastric cancer has increased, preventing further risks. The region is anticipated to expand modestly at a CAGR of 4.5%.

“The global helicobacter pylori non-invasive testing market shows modest future growth prospects. The increasing prevalence of h. pylori associated diseases have prompted manufactures to invent non-invasive testing and treatment methods to reduce the incidence of such diseases,” concludes a Fact.MR analyst.

global helicobacter pyroli (h.pyroli) non invasive treatment market 01

Global Helicobacter Pylori Non-Invasive Testing Market: Competitive Landscape:

The global H. Pylori non-invasive testing market comprises of the following market players: Meridian Bioscience, Inc., DiaSorin S.p.A, Alere, Sekiusi Diagnostics and Biomerica, Inc. Besides these, a host of other players have a significant market presence as well. These are Biohit Oyj, Exalenz Bioscience Ltd., Aalto Bio Reagents Ltd., Certest Biotec S.L. and CorisBioconcept SPRL.

Meridian Bioscience, Inc. markets its tests and assay kits to hospitals, reference laboratories and other diagnostic manufacturers in more than 60 countries. Its H. Pylori testing products include the Premium Platinum HpSA PLUS or Premium H. Pylori. It is an in vitro qualitative procedure to detect the presence of H. Pylori bacteria in the human stool.

Exalenz Biosciences manufactures the H. Pylori IgG ELISA Kit, BreathID HP, BreathID Smart and Breath ID Lab devices. These devices conduct a quick and accurate Urea Breath Test for diagnosing H. Pylori infection and confirming post-treatment eradication. The test is conducted in real-time by continuously sampling breath, eliminating the need for sample collection, labeling, transport and analysis.

Request More Information about Report Methodology https://www.factmr.com/connectus/sample?flag=RM&rep_id=4774

COVID-19 Market Insights:

Although there is a dearth of evidence suggesting any links between the COVID-19 and H. Pylori infections, experts have concluded that patients need to be provided treatment on a priority basis. This is because the COVID-19 infection affects the gastrointestinal tract, inducing nausea, vomiting and diarrhea. Since H. Pylori primarily infects the GI tract, it is important for those patients to be provided immediate medical attention if infected with the COVID-19.

As the pandemic is spreading at an exponential rate, key manufacturers are accelerating their efforts to contain its spread. This involves redirecting their resources towards developing COVID-19 testing kits. For instance, Meridian Bioscience has launched the QuickPac II 2019 COVID-19 IgG and IgM qualitative testing kit for the detection of potential antibodies to combat the novel coronavirus strain in the human serum, plasma or blood. Similarly, DiaSorin S.p.A announced the launch of its LIAISON SARS CoV-2 S1/S2 IgG serological test. Such developments are anticipated to shift focus away from H. Pylori testing, leading to a dip in its demand. However, patients requiring urgent care will be provided with the appropriate treatment.

Looking for more information?

The research study on the global helicobacter pyroli (h. pyroli) non-invasive testing market by Fact.MR incorporates an unbiased assessment of key factors and trends responsible for shaping the landscape of the global helicobacter pyroli (h. pyroli) non-invasive treatment market over 2020-2026.

It includes a detailed assessment of key parameters that are anticipated to exert influence during 2020-2026. Market statistics have been presented on the basis of Non-invasive Test Type (Serology Test, Stool Antigen Test and Urea Breath Test), Test Method (Laboratory Based Tests and Point-of-Care Tests) and End User (Hospitals, Diagnostic Laboratories and Clinics) across five major regions.

Explore Fact.MR’s Coverage on the Healthcare Domain

Microcirculation Microscope Market: A recent study by Fact.MR on the Microcirculation Microscope market offers an unbiased analysis on the opportunities and trends through 2021 and beyond. The study analyzes crucial trends that are currently determining market growth. This report explicates on vital dynamics, such as the challenges, restraints, and opportunities for key market players along with key stakeholders and emerging players.

Scanning Probe Microscopes Market: A detailed assessment of Scanning Probe Microscopes market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the market along with their product portfolios enhances the reliability of this comprehensive research study.

Microscopy Devices Market: Fact.MR delivers a detailed analysis on global Microscopy Devices market with the strategies and competitive landscape for the upcoming period. The key players’ market share data provided by the report given you a detailed insights on the shortcomings and forthcomings of the market for the forecast period.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Research Insight: https://www.factmr.com/report/4774/helicobacter-pylori-hpylori-noninvasive-testing-market
Press Release: https://www.factmr.com/media-release/1538/global-helicobacter-pylori-hpylori-noninvasive-testing-market
Follow Us: LinkedIn | Twitter

Categories
Pharmaceutical

Endoscopic Clips Market is anticipated to register a staggering CAGR of 7.3% by 2026

The scope of endoscopic treatment has witnessed an upsurge in recent years, attributed to rising cases of various internal diseases. Endoscopic clips are widely used in closing perforations, lesions and bleeding arteries. This extensive utilization has prompted several companies to invest heavily in designing diverse endoscopic clips, endowed with state-of-the-art modern technology, such as computer-aided surgical sedation.

Based on these trends, the global demand for endoscopic clips market is set to witness an upswing during the forecast period (2020-2026). Projections indicate an impressive CAGR of 7.3%, pegged to reach a value pool of US$ 617.0 Mn. Other generic factors such as an increased geriatric population pool and rising cases of disease requiring endoscopic treatment are also expected to drive the growth of the endoscopic clips market.

Request a report sample to gain comprehensive insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=4753

Key Takeaways of Global Endoscopic Clips Market Study:
  • Hemostatic Endoscopy is set to capture the maximum market share in terms of application. This is attributed to its importance in stemming bleeding and wound healing. The hemostasis segment is anticipated to account for almost half the market, expanding at a CAGR of 7.8%.
  • Hospitals are anticipated to register maximum usage of hemostatic endoscopic clips during the forecast period, reaching a value of US$ 333.9 Mn by 2026. A staggering CAGR of 7.8% is projected for this segment. Favorable reimbursement plans and increase in the number of treatment cases shall augment hospitals’ market share.
  • North America shall remain the kingpin in the global endoscopic clips market. Investments in technologically-rich research and treatment platforms, large market presence of key manufacturers and increasing prevalence of GI tract  cancers is augmenting North America’s market share. The region is anticipated to capture almost two-fifth of the marker share, expanding at a CAGR of 7.2% during the forecast period.
  • East-Asia shows impressive growth opportunity in the endoscopic clips market. An untapped market combined with robust economic development and a burgeoning health sector are set to drive market growth in this region. Projections indicate a robust CAGR of 7.6% in the forecast period.
  • Rising COVID-19 cases are anticipated to hamper market growth. This is attributed to the call for delaying elective procedures in favor of emergency ones.
  • Leading endoscopic clips manufacturers have taken proactive steps to limit the spread of the disease. Cook Medical, for instance, has encouraged its employees to work remotely while visitors are strongly discouraged from visiting manufacturing facilities.
  • Boston Scientific is a beneficiary of the Coronavirus Aid, Relief and Economic Security (CARES) Act. The act offers economic support to healthcare providers by covering COVID-19 treatment costs and covering up lost revenue due to delayed elective procedures. Likewise, Olympus Corporation has restricted endoscopic clips production and urged its employees to work from home.

global endoscopic clips market image 01

“The global endoscopic clips market is anticipated to remain on a positive growth trajectory in the future. Ongoing research and development in advanced endoscopy procedures and product launches are anticipated to provide a boost to the market,” concludes a Fact.MR analyst.

Request More Information about Report Methodology  https://www.factmr.com/connectus/sample?flag=RM&rep_id=4753

Broad Market Presence and Cross Selling Opportunities to Boost Market Growth

Highly consolidated, the global endoscopic clips market is dominated by three players: Boston Scientific Corporation, Cook Medical and Olympus Corporation. These companies concentrate on broad market presence, cross-selling opportunities, and new product launches.

Boston Scientific Corporation’s radiopaque Resolution Clip is designed for hemostasis, endoscopic marking, closure and anchoring of jejunal feeding tubes. It also carries a CE-mark prophylactic clipping to reduce the risk of delayed bleeding post lesion resection. Moreover, the device is equipped with a pushable sheath construction and smooth needle penetration to reduce trauma to the patient.

Another leader, Olympus Corporation, manufactures the QuickClip series endoscopes like the QuickClip2- Single use rotatable clip fixing devices, QuickClip2 Long and EZ Clips.

They offer precise rotation providing exclusive control in orienting the clip, increased flexibility and easy penetration and channel protection. The third player, Cook Medical, manufactures endoscopic clips through its Instinct Endoscopic Hemoclip series, suitable for endoscopic marking, hemostasis and mucosal/submucosal defects less than 3 cm in the upper GI tract.

Looking for more information?

The research study on the global endoscopic clips market by Fact.MR incorporates an unbiased assessment of key factors and trends responsible for shaping the landscape of the global endoscopic clips market over 2020-2026. It includes a detailed assessment of key parameters that are anticipated to exert influence during 2020-2026. Market statistics have been presented on the basis of Application (Endoscopic Marking, Hemostasis and Others.) and End-users (Hospitals, Ambulatory Surgical Centers, Clinics and Others) across five major regions.

Explore Fact.MR’s Coverage on the Healthcare Domain

Microcirculation Microscope Market: A recent study by Fact.MR on the Microcirculation Microscope market offers an unbiased analysis on the opportunities and trends through 2021 and beyond. The study analyzes crucial trends that are currently determining market growth. This report explicates on vital dynamics, such as the challenges, restraints, and opportunities for key market players along with key stakeholders and emerging players.

Scanning Probe Microscopes Market: A detailed assessment of Scanning Probe Microscopes market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the market along with their product portfolios enhances the reliability of this comprehensive research study.

Microscopy Devices Market: Fact.MR delivers a detailed analysis on global Microscopy Devices market with the strategies and competitive landscape for the upcoming period. The key players’ market share data provided by the report given you a detailed insights on the shortcomings and forthcomings of the market for the forecast period.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Research Insight: https://www.factmr.com/report/4753/endoscopic-clips-market
Press Release: https://www.factmr.com/media-release/1517/global-endoscopic-clips-market
Follow Us: LinkedIn | Twitter

Categories
Pharmaceutical

Arterial Stents Market worth US$ 17,887.9 Million by 2025 – Exclusive Report by Fact.MR

Rising incidences of cardiovascular diseases has prompted people to seek timely treatment to improve life expectancies. Amongst all cardiovascular diseases, coronary heart disease accounts for maximum fatalities annually, claims the American Heart Association (AHA). Increased burden of cardiovascular diseases has compelled patients to seek new trends in treatment.

In the wake of this, the demand for minimally invasive surgical procedures has accelerated. Stents are the most preferred method for correcting cardiac anomalies in this respect. This is because the insertion of stents prevents restenosis. Therefore, the demand for arterial stents market is poised to expand impressively at a CAGR of 9.8% during the forecast period (2020-2025).

Request a report sample to gain comprehensive insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=4713

Key Trends from the Arterial Stents Market Study:
  • Coronary Stents shall dominate the arterial stents market. This is because of an increasing number of coronary artery disease patients and affordability of coronary stents. Anticipated market share is three-fifths of the overall market, growing almost twofold during the forecast period.
  • Simultaneously, the Femoral & Popliteal Artery segment is set to experience robust growth. This is attributed to growing Percutaneous Coronary Intervention (PCI) procedures in correcting heart ailments. An impressive 10.2% CAGR is projected for this segment.
  • Europe is anticipated to dominate the arterial stents market owing to strategic presence of key market players in the interventional cardiology market. An impressive 9.6% CAGR is projected for the region. Moreover, majority of the patients here opt for coronary artery stents, due to a high number of PCI procedures.
  • Asia-Pacific is not very far behind, registering a healthy CAGR of 10.3% during the forecast period. Market penetration by important players and affordability of stents is projected to drive the growth of the region. Coronary Stents are anticipated to hold more than three-fifths of the arterial stents market.
  • Downsizing of production of arterial stents is anticipated, owing to the spread of the COVID-19 pandemic. Rising infection rates have shifted priority towards addressing patients with COVID-19. This has relegated non-emergency procedures to the backyard, creating a backlog of cardiac patients. However, cardiac complications arising due to the COVID-19 infection such as arrhythmia and tachycardia will be given top priority.
  • Important players such as Boston Scientific Corporation have been contributing significantly to mitigate the spread of the disease. The company has taken significant steps to reduce costs by optimizing manufacturing and output prices and reduction in discretionary spending. It has also undertaken monetary and supply donations along with provision of manufacturing expertise and resources.

“The arterial stents market is projected to embark on a positive growth trajectory, driven primarily by increased demand for minimally invasive surgical procedures. To that end, manufacturers are concentrating heavily on product development and expansion of their portfolio,” concludes a Fact.MR analyst.

Market Players Resort to Product Distribution to Expand Market Share

Highly fragmented, the arterial stents market is dominated by more than 50 players. Out of these, three key players- Medtronic, Abbott Laboratories and Boston Scientific Corporation- account for three-tenth of the market share.

Boston Scientific Corporation is the leading player. Its product categories include coronary intervention and peripheral intervention. It specializes in Drug-eluting stents such as Epic, Express & Innova, Self-expanding Stents such as Synergy, Eluvia and Flexive and Bare Metal Stents like Rebel & Promus.

Request More Information about Report Methodology  https://www.factmr.com/connectus/sample?flag=RM&rep_id=4713

Abbott Laboratories, through its Abbott Vascular branch, offers a broad range of endovascular devices and cardiovascular stents. The products it manufactures include Xience Alpine and Xience Xpedition, which are Drug-eluting and Bare Metal Stents respectively, Absolute Pro and Omnilink which are Self-Expanding Stents and RX Acculink which is a Balloon-expanding Stent.

Looking for more information?

The research study on the arterial stents market by Fact.MR incorporates an unbiased assessment of key factors and trends responsible for shaping the landscape of the arterial stents market over 2020-2025. It includes a detailed assessment of key parameters that are anticipated to exert influence during 2020-2025. Market statistics have been presented on the basis of Product (Coronary Stents and Peripheral Stents) and Application (Coronary Artery, Carotid Artery, Iliac Artery, Femoral & Politeal Artery & Others) across five major regions.

Explore Fact.MR’s Coverage on the Healthcare Domain

Microcirculation Microscope Market: A recent study by Fact.MR on the Microcirculation Microscope market offers an unbiased analysis on the opportunities and trends through 2021 and beyond. The study analyzes crucial trends that are currently determining market growth. This report explicates on vital dynamics, such as the challenges, restraints, and opportunities for key market players along with key stakeholders and emerging players.

Scanning Probe Microscopes Market: A detailed assessment of Scanning Probe Microscopes market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the market along with their product portfolios enhances the reliability of this comprehensive research study.

Microscopy Devices Market: Fact.MR delivers a detailed analysis on global Microscopy Devices market with the strategies and competitive landscape for the upcoming period. The key players’ market share data provided by the report given you a detailed insights on the shortcomings and forthcomings of the market for the forecast period.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Research Insight: https://www.factmr.com/report/4713/arterial-stents-market
Press Release: https://www.factmr.com/media-release/1460/global-arterial-stents-market
Follow Us: LinkedIn | Twitter

Categories
Pharmaceutical

Circulating Tumor Cells (CTC) Diagnostics Market is expected to Account for Over US$ 9.5 Million in 2030

Circulating tumor cells (CTCs) are a blistering topic of oncological conferences and research due to their tremendous potential in the area of cancer diagnosis as well as treatment. The amount of research that CTCs have been doled with signals the lucrative growth prospects of the CTC diagnostics market, which is likely to surpass the valuation of over US$ 9.5 billion by 2030 – projects a recent study published by Fact.MR.

The study highlights the potential for the CTC enrichment technologies in the area of CTC diagnostics and remains bullish on the profitability of investments made in this space. The potentiality of CTC diagnostics is not limited to diagnosing the presence of a tumor, but it also goes beyond that to help in finding the core information about that tumor. In the coming years, the significance of CTC diagnostics in cancer therapies and treatment is expected to remain substantial and the market will witness astonishing growth in the coming decade, opines the Fact.MR study.

Request a report sample to gain comprehensive insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=5510

Key Takeaways from CTC Diagnostics Market Report
  • The CTC diagnostics market has surpassed the mark of US$ 6 billion, as it reached the valuation of US$ 6.3 billion in 2020. The primary factor to drive the market remains the ongoing research in the field of cancer diagnostics and alarmingly increasing number of cancer deaths around the world.
  • The market is expected to witness exponential growth in the coming decade as the projected CAGR is likely to exceed beyond 17% during the forecast period of 2020 to 2030.
  • The adoption of CTC enrichment methods is likely to remain significantly high, as the segment is projected to reach the valuation of over US$ 9.5 billion by the end of the assessment period.
  • The North American market for CTC diagnostics is expected to lead the regional category with a valuation of over US$ 2 billion in 2020. With the ongoing cancer research in the region and growing presence of market leaders, the regional market is expected to secure one-third revenue share in the global space.
  • Patients’ inclination towards non-invasive diagnostics tests and prognostic tools for predicting or detecting the risks of cancer is one of the driving forces for the growth of the market. Manufacturers are also expected to experiment around technologies for detection and analyzing CTCs to improve accuracy and reliability of results.

circulating tumor cell ctc diagnostics market regional

“The CTC diagnostics technology possesses the ability to detect, identify, quantify, and analyze cancer tumors in blood samples of patients. It is gaining immense demand in the area of cancer diagnostics as patients’ inclination toward non-invasive tests is significantly high. Players in the CTC diagnostics market must tap into opportunities in the area of targeted cancer research and diagnosis to benefit from the great potential that CTC diagnostics carry in the cancer diagnostics landscape in the coming years,” says a lead analyst at Fact.MR.

Request More Information about Report Methodology https://www.factmr.com/connectus/sample?flag=RM&rep_id=5510

CTC Diagnostics: An Inevitable Step in Targeted Cancer Stem Cell Research

The incidence of cancer is alarming across the world, and researchers are constantly on their toes to improve the diagnostics and cancer treatments to reduce the avoidable cancer deaths. CTC diagnostics is emerging as an important area of cancer stem cell research as the reliability of using CTC counts from blood samples of patients can help doctors and oncologists to make an appropriate choice of frontline cancer therapy. A mounting number of researchers are implementing CTC diagnostic technologies in cancer stem cell research as it provides doctors with a decision algorithm so as to opine on which treatment to choose.

More Valuable Insights on the CTC Diagnostics Market

Fact.MR has published a study on the CTC diagnostics market which offers a detailed assessment on how the CTC diagnostics market will grow and expand in the coming decade. The report analyzes the statistics related to the market growth during the historic period of 2015-2019, and with the help of which, it offers the detailed assessment on growth projections for the landscape during the forecast period of 2020-2030.

Fact.MR’s report categorises the insights on the CTC diagnostics market in the form of product (Devices & Systems, Kits & Reagents, Other Consumables), technology (CTC Enrichment Methods, CTC Detection Methods, and CTC Analysis), application (Cancer Stem Cell Research, EMT Biomarkers Development, Tumorigenesis Research, and Others), sample type (Blood, Bone Marrow, and Others), and seven key regions (North America, Latin America, East Asia, South Asia, Oceania, Middle East & Africa, and Europe).

Explore Fact.MR’s Coverage on the Healthcare Domain

Microcirculation Microscope Market: A recent study by Fact.MR on the Microcirculation Microscope market offers an unbiased analysis on the opportunities and trends through 2021 and beyond. The study analyzes crucial trends that are currently determining market growth. This report explicates on vital dynamics, such as the challenges, restraints, and opportunities for key market players along with key stakeholders and emerging players.

Scanning Probe Microscopes Market: A detailed assessment of Scanning Probe Microscopes market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the market along with their product portfolios enhances the reliability of this comprehensive research study.

Microscopy Devices Market: Fact.MR delivers a detailed analysis on global Microscopy Devices market with the strategies and competitive landscape for the upcoming period. The key players’ market share data provided by the report given you a detailed insights on the shortcomings and forthcomings of the market for the forecast period.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Research Insight: https://www.factmr.com/report/circulating-tumor-cells-ctc-diagnostics-market
Press Release: https://www.factmr.com/media-release/1818/global-circulating-tumor-cells-ctc-diagnostics-market
Follow Us: LinkedIn | Twitter

Categories
Pharmaceutical

Medical Flexible Packaging Market is projected to register a moderate CAGR growth of 4.6% by the end of 2022

Fact.MR, in its new report, anticipates the global demand for medical flexible packaging market to register a moderate growth over the forecast period 2017 to 2022. Sales of medical flexible packaging across the globe are expected to account for over US$ 25,000 Mn revenues by 2022-end.

Various advantages are offered by medical flexible packaging, which include easy shipping, low waste, and product protection, along with the capability of lowering the overall weight of packaging by approximately 70%. Medical flexible packaging provides product and price differentiation to consumers, and aids the preservation of medical devices’ health and hygiene value.

Request a report sample to gain comprehensive insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=247

Huge growth opportunities for pharmaceutical and medical device manufacturers are expected to be witnessed across developing countries, which in turn will drive demand for medical flexible packaging in these regions. Currently struggling in stagnant but mature markets, with a lot of regulatory barriers, and patent expirations, leading market players are adopting key strategies such as regional expansion, and brand positioning.

medical flexible packaging market

Flexible packaging manufacturers are focusing on increasing their presence in developing economies, in a bid to benefit themselves from low-cost labor, and enhance their product offerings. These manufacturers are also focusing on diversification and combination of data analytics with the manufactured products, in order to develop new novel technologically driven products.

Other factors expected to impact the market growth include effective supply chain management, attractive packaging, useful tool for identification & branding, prevention of product damage, and higher efficiency in transporting products. However, factors such as stringent government regulations pertaining to recycling of packaging materials, and use of polymers, are expected to curb growth of the market during the forecast period.

Request More Information about Report Methodology https://www.factmr.com/connectus/sample?flag=RM&rep_id=247

5 Key Future Prospects of Medical Flexible Packaging Market for Forecast Period 2017 to 2022
  1. In terms of revenues, polyvinyl chloride will continue to be the most attractive material utilized for medical flexible packaging. Sales of paper for producing medical flexible packaging products are expected to exhibit a relatively faster expansion through 2022, based on materials.
  2. Medical flexible packaging are expected to find the largest application in pharmaceutical manufacturing over the forecast period. In addition, sales of medical flexible packaging products for application in implant manufacturing and contract packaging are poised to register a relatively higher CAGR through 2022.
  3. On the basis of product, seals will continue to be dominant in the global medical flexible packaging market, in terms of revenues. High-barrier films are expected to be the second most lucrative product in the market. However, wraps are anticipated to witness the fastest expansion in sales through 2022.
  4. North America will dominate the global medical flexible packaging market in 2017, and the trend is projected to continue during 2017 to 2022. Revenues from the medical flexible packaging market in North America are expected to exceed US$ 7,000 Mn by 2022-end.
  5. Key players projected to lead the global medical flexible packaging market are Datwyler Holdings, Aptar Group, Inc., Reynolds Group Holdings, Berry Group, Inc., Sonoco Products Company, Coveris Holdings S.A., Catalent, Inc., Becton Dickinson & Company, Constantia Flexibles Group GmbH, Mondi Group Plc, Huhtamaki Oyj, Sealed Air Corporation, Bemis Company, Inc., and Amcor Limited.

North America is projected to remain the largest market for medical flexible packaging, with sales poised to surpass US$ 7,000 Mn in revenues by 2022-end. In addition, Europe and North America will exhibit a parallel expansion at equal CAGRs through 2022.

Wraps are expected to be the fastest-selling product in the global medical flexible packaging market. Seals will continue to be the most lucrative product in the market, followed by high-barrier films.

On the basis of application, contract packaging and implant manufacturing are expected to witness a relatively faster expansion through 2022. Pharmaceutical manufacturing will remain the largest application of medical flexible packaging during the forecast period.

Explore Fact.MR’s Coverage on the Healthcare Domain

Microcirculation Microscope Market: A recent study by Fact.MR on the Microcirculation Microscope market offers an unbiased analysis on the opportunities and trends through 2021 and beyond. The study analyzes crucial trends that are currently determining market growth. This report explicates on vital dynamics, such as the challenges, restraints, and opportunities for key market players along with key stakeholders and emerging players.

Scanning Probe Microscopes Market: A detailed assessment of Scanning Probe Microscopes market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the market along with their product portfolios enhances the reliability of this comprehensive research study.

Microscopy Devices Market: Fact.MR delivers a detailed analysis on global Microscopy Devices market with the strategies and competitive landscape for the upcoming period. The key players’ market share data provided by the report given you a detailed insights on the shortcomings and forthcomings of the market for the forecast period.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Research Insight: https://www.factmr.com/report/247/medical-flexible-packaging-market
Press Release: https://www.factmr.com/media-release/237/medical-flexible-packaging-market
Follow Us: LinkedIn | Twitter

Categories
Pharmaceutical

Sales of Dental Biomaterials Is Anticipated to Reach a Value of US$ 10,236.6 by 2025

With a large proportion of the global population focusing on oral health, the incidences of dental decay are fast diminishing. As treatment for dental problems have burgeoned, a significant shift in the nature of dental care services is obvious- from conventional restorative care to cosmetic and preventive services. As a consequence, demand for technologically superior dental devices has augmented.

On the back of this trend, the demand for dental restorative is poised to experience an impetus in the future, expanding 1.5x during the forecast period (2020-2025). A staggering CAGR of 6.8% is predicted for the market. Increasing dental complications amongst the elderly and the subsequent increase in dental tourism are also projected to leverage the dental restorative market.

Click HERE To get a SAMPLE (Including Full TOC, Table & Figures) at
https://www.factmr.com/connectus/sample?flag=S&rep_id=4725

Delaying of elective dental procedures and non-urgent surgeries is anticipated to slow growth prospects for the dental restoratives market. Concerns about the virus’s spread by virtue of saliva and aerosols employed by dentists in dental procedures are important considerations.

“The dental restoratives market demonstrates a healthy growth potential in the future. Rising adoption of sophisticated dental restoration techniques in implants, prosthetics and restorative equipment are boosting prospects for key players,” concludes a Fact.MR analyst.

Need more information about Report Methodology? Click here-
https://www.factmr.com/connectus/sample?flag=RM&rep_id=4725

global dental restoratives market 01

Dental Restoratives Market Segmentation

Fact.MR has studied the dental restoratives market with detailed segmentation on the basis product type, end-user and key regions.

Product Type

  • Restorative Equipment:
  • CAD/CAM & Dental Delivery Systems
  • Rotary Instruments
  • Light Curing Equipment
  • Casting Devices
  • Mixing Devices
  • Dental Drills
  • Dental Furnace
  • Articulating Equipment
  • Restorative Material:
  • Direct Restorative Dental Material
  • Indirect Restorative Dental Material
  • Biomaterials
  • Bonding Materials
  • Dental Impression Materials
  • Prosthetics
  • Implants

End-user

  • Hospitals
  • Dental Clinics
  • Dental Institutes & Research Centers
  • Others

Key Regions

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Full Access of this Exclusive Report is Available at- https://www.factmr.com/checkout/4725

Key Takeaways of the Dental Restorative Market Study:

  • Restorative material shall find widespread usage amongst dental practitioners, capturing a market share of 30% throughout the forecast period. This is attributed to increased usage of biomaterials in dental procedures and implants.
  • Dental clinics shall capture the maximum market share by end-user, amounting to two-fifth of the total market. The segment is projected to grow healthily at a CAGR of 7.5% during the forecast period. Availability of modern equipment, combined with low cost and free treatment shall augment demand from this end user. This is followed by the hospitals segment, set to expand at a CAGR of 6.8% throughout the forecast period.
  • Europe is set to dominate the overall dental restorative market, accounting for more than one-third of the total market share. Adequate insurance cover provided by insurance companies for dental procedures is expected to burgeon the region’s market share.
  • However, Asia-Pacific shows lucrative growth opportunities, in the wake of increasing dental tourism to emerging dental hubs. The region is set to expand robustly at a CAGR of 8.1%.
  • The global dental restoratives market is anticipated to register a moderate decline in the face of the COVID-19 pandemic. This is attributed to the postponement of elective and non-urgent dental restorative surgeries to a future date. It has been established that dental surgeons are at a high risk of contracting the COVID-19 infection through the patient’s saliva. Dentists performing aerosol generating procedures are at an equally high risk as they may involuntarily inhale them, allowing the virus to travel to the lungs.
  • Leading manufacturers of dental restorative implants and devices are leveraging their platforms to aid in the crusade against COVID-19. For instance, Dentsply Sirona is encouraging its non-manufacturing staff to work remotely from home and has eliminated all non-essential cross border travel to contain the virus. The company is also investing in maintaining its supply chain, by having a diverse manufacturing footprint, adequate inventory and strong logistical capabilities.
  • Some players are offering practitioners online courses to help them cope with the aftermath of the COVID-19 crisis. Straumann group, for instance, is offering online business courses and recovery plans courses to dental professionals. An example of this is the ImmediaXy Ecosystem which brings immediate implant protocols to the next level by shortening treatment times and increasing productivity of dental professionals.

Manufacturers Prioritize Product Development to Broaden Market Footprint

Highly consolidated, the dental restorative market consists of the following key market players: Dentsply Sirona, Danaher, Institut Straumann AG, Ivoclar Vivadent AG and Zimmer Biomet. Product development remains a core strategy of the abovementioned players. For instance, Dentsply Sirona, a pioneer in the dental restorative market, produces restorative materials, implants, prosthetics and restorative equipment. In addition, the company was recently designated as having one of the most modern dental clinics in Europe.

Another player, Institut Straumann AG, manufactures implants such as Straumann BLX with a Regular Base (3.5 mm-4.5 mm) and Wide Base (5.0 mm-6.5 mm). These implant allow for Straumaan Dynamic Bone Management and is designated for immediate protocols in all bone types. Other products include Roxolid SLActive, n!ce, VITA Mark II and ZERION.

Get More Insights –
https://www.biospace.com/article/bone-marrow-processing-systems-growth-driven-by-progressions-in-bone-marrow-needles-and-harvest-technology-says-fact-mr/

Looking for more information?

The research study on the audiological market by Fact.MR incorporates an unbiased assessment of key factors and trends responsible for shaping the landscape of the dental restoratives market over 2020-2025. It includes a detailed assessment of key parameters that are anticipated to exert influence during 2020-2025. Market statistics have been presented on the basis of Product (Restorative Equipment, Restorative Material, Prosthetics and Implants) and End-user (Hospitals, Dental Clinics, Dental Institutes & Research Centers and Others) across five major regions.

Fact. MR’s Domain Knowledge in Healthcare

Fact .MR’s healthcare and research professionals guide organizations at each step of their business strategy by helping you understand how contemporary influencers impact transformation in the healthcare sector. Our expertise in recognizing the challenges and trends affecting the global healthcare industry provides valuable insight and support, helping identify critical issues and construct relevant solutions.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com
Content Source: https://www.factmr.com/media-release/1474/global-dental-restoratives-market

Categories
Pharmaceutical

Augmenting Demand for Contraceptives Vaginal Rings to Bolster Global Market Revenue Growth During the Crisis Period of COVID-19

Prevalence of unwanted pregnancies has necessitated the need to seek more effective contraceptive treatment. A majority of these pregnancies occur among adolescents and young women and are the principal source of the spread of sexually transmitted infections. These include HIV, chlamydia, genital herpes and hepatitis B. Concerned by this, governments across the world have heavily invested in sexual education programs in order to acquaint people with the dangers of such diseases. The Sales of contraceptives in the Asia-Pacific are projected to surpass a value of US$ 7,925.7 by the end of 2025, expanding at a CAGR of 6.8%.

For detailed insights on enhancing your product footprint, request for a sample here-
https://www.factmr.com/connectus/sample?flag=S&rep_id=4719

“The global contraceptives market is expected to be leveraged significantly in the future, driven by accelerating instances of sexually transmitted infections. This has encouraged key market players to invest in research and development of effective contraceptive techniques. This shall be a significant growth driver,” concludes a Fact.MR analyst.

Propelled by these abovementioned factors, the global contraceptives market is set to expand positively during the forecast period (2020-2025). The global contraceptives market is projected to reach a value of US$ 37,242.7 by 2025-end, expanding at a CAGR of 6.4%. Other developments such as introduction of innovative devices is also expected to boost market growth for contraceptives.

Need more information about Report Methodology? Click here-
https://www.factmr.com/connectus/sample?flag=RM&rep_id=4719

Mandatory social distancing amid the COVID-19 pandemic, however, is anticipated to generate tremors in the global contraceptives market supply chain, owing to limited production capacity due to less employee strength and avoidance of physical contact among adults.

global contraceptives market 01

Key Takeaways of Global Contraceptives Market Study

  • Contraceptive devices shall capture the maximum market share of the global contraceptives market (>50%). This is attributed to the major side effects of ingesting contraceptive drugs, such as nausea, headache, weight gain, increased bleeding, dysmenorrhea and menstrual changes, among women. The introduction of custom-fit condoms by key market players is equally expected to boost market share. Anticipated CAGR for the forecast period is pegged at 6.6%.
    • Hospitals shall account for the maximum distribution of contraceptive devices among patients. Favorable reimbursement policies to hospitals is a key driver behind the growth of this segment. Projections indicate a market share of one-third during the forecast period.
    • North America shall dominate the global contraceptives market, due to increased incidences of unwanted pregnancies and burgeoning demand for reversible contraceptives among the patients. The region is expected to surpass a valuation of US$ 12.9 Bn growing at a CAGR of 6.6% during the forecast period.
    • Asia-Pacific shows high potential for growth of the global contraceptives market. The region shows staggering prospects, with a CAGR pegged at 6.8% throughout the forecast period.
  • The COVID-19 pandemic is anticipated to initiate a decline in the sales of contraceptives globally. This is attributed to social distancing among young adults in order to contain the spread of the virus. This includes refrainment from any kind of physical contact, including sexual intercourse.
  • Supply-chain disruptions are anticipated, attributed to limited production capacity of manufacturing plants. Condoms, the most popular contraceptive, are anticipated to register significant downturn in production. The Asian market is poised to experience the maximum shortage as most condoms are produced in China and Indonesia.
  • Fortunately, healthcare practitioners and key manufacturers are taking proactive measures to ensure minimum supply-chain disruptions to the global contraceptives market. To that end, the UN Population Fund (UNFPA) has urged governments across the world to encourage public and private partnerships to mobilize the private sector and enhance the supplies of sanitary items, medical equipment and antiretroviral drugs. The fund also calls for appropriate administration and in-country distribution of required sexual and reproductive health (SRH) products and unceasing investment in strengthening the reproductive and sexual health supply chain.

Full Access of this Exclusive Report is Available at-
https://www.factmr.com/checkout/4719

Global Contraceptives Market: Competitive Landscape

With a highly fragmented market, several important players dominate the contraceptives market. Some of the key market players are: Allergen, plc, Pfizer, Inc, Teva Pharmaceutical Industries Ltd., Bayer AG and Janssen Pharmaceutical Company. The companies primarily concentrate on product launches in order to broaden their market footprint. Pfizer Inc, for instance, manufactures Sayana Press, an injectable contraceptive for women available in the U.K. The company is also in the process of conducting a study evaluating levonorgestrel and ethinyl estradiol as potential oral contraceptives.

Merck & Co, Inc., offers contraceptive care in the form of combined oral pills, vaginal rings, intrauterine devices and sub-dermal implants. Popular products include Cyclessa, Desogen, NuvaRing, Implanon and Nexplanon. Another important player, Cipla, manufactures oral contraceptives named Crisanta. The medicine contains Drospirenone which prevents the fertilization of the egg with the sperm. It also induces hormonal changes contributing to the prevention of pregnancy.

High Purity Quartz Sand Industry Survey Report by Fact.MR –https://www.youtube.com/watch?v=ItwHQrt-vmY

Looking for more information?

The research study on the global contraceptives market by Fact.MR incorporates an unbiased assessment of key factors and trends responsible for shaping the landscape of the global contraceptives market over 2020-2025. It includes a detailed assessment of key parameters that are anticipated to exert influence during 2020-2025. Market statistics have been presented on the basis of Product (Contraceptive drugs and Contraceptive devices) and Distribution Channel (Hospital Pharmacy, Independent Pharmacy, Online Platforms, Clinics and Others) across five major regions.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

Demand for Battery Powered Breast Pumps Is Projected to Expand at a Staggering CAGR of 9.4% Over the Assessment Period

The novel Coronavirus (COVID-19) is changing the course of business activities of companies in the keyword market. Companies are becoming increasingly conscious about preventive and hygiene measures at production sites to inhibit the chain of infection. Gain access to our full report that highlights key insights associated with COVID-19, where companies can adopt new strategies to tackle the challenges

The number of working women has increased substantially in the past several years. Many corporate and non-corporate organizations are hiring women within their workforce and offering high-paying jobs. As most of their dedication is devoted towards their work, many young mothers find limited time to take care of their infants. Since infants require regular breast milk intake, women are increasingly relying on breast pumps to feed their babies. Global demand for breast pump is projected to expand at a staggering CAGR of 9.4% during the forecast period (2020-2025)

For detailed insights on enhancing your product footprint, request a sample here-

https://www.factmr.com/connectus/sample?flag=S&rep_id=4690

Based on this trend, the global breast pumps market is prophesied to expand healthily during the forecast period (2020-2025), expanding 1.7x. Other growth drivers ensuring a positive growth trajectory include rising insurance coverage for breast pumps, increased awareness about breastfeeding and technological advancements in breast pump feeding techniques.

A detailed assessment of the global breast pumps market value chain analysis, business execution, and supply chain analysis across the regional markets has been covered in the report. A list of prominent companies operating in the global breast pumps market along with their product portfolio enhances the reliability of this comprehensive research study.

“The global breast pumps market has a positive future ahead. The burgeoning trend of working women and rising birth rates shall provide impetus for future growth. Taking this into account, leading manufacturers are concentrating on strengthening their base by targeting lucrative markets to increase their sales,” concludes a Fact.MR analyst.

global breast pumps market 02

Need more information about Report Methodology? Click here-

https://www.factmr.com/connectus/sample?flag=RM&rep_id=4690

Key Takeaways from the Global Breast Pumps Market Study:

  • By product, double-electric breast pumps are poised to find increased usage among women. Technological advancements as well as increased insurance coverage by public and private sectors is anticipated to boost the segment’s growth. An example of technological advancements in breast pumps is the Willow Breast Pump. It is a hands-free, cordless and noiseless pump which extracts milk without the slightest discomfort to women. Anticipated CAGR for this segment is a whopping 10.4%.
  • However, single-electric breast pumps shall register equally widespread usage, attributed to its affordability, faster pumping rate, portability and potency. The segment is anticipated to expand staggeringly at a CAGR of 9.7% across the forecast period. It is poised to capture over 2/5th of the global breast pumps market.
  • Application-wise, the personal use segment is projected to dominate the global breast pumps market. Government initiatives to create awareness about the benefits of breast feeding has prompted consumers to opt for personal usage of breast pumps. In addition, technological advancements in electric breast pumps and increase in working women workforce shall augment market growth. The segment is set to expand healthily at a CAGR of 10.4%.
  • By region, North America is poised to capture the maximum market share with regard to global breast pumps. Increasing government initiative to spread awareness about breastfeeding, growing healthcare expenditure and unfavorable maternity leave policies are key growth levers. Anticipated CAGR for North America is 9.8%.
  • Asia-Pacific shows lucrative market opportunities for the global breast pumps market, expanding at a CAGR of 10.0%. Rising birth rates, increased disposable incomes and greater women workforce as well as entry of market players are poised to drive the region’s growth in a positive direction.
  • The COVID-19 pandemic is poised to have a moderate impact on the production and distribution of breast pumps. The sales are anticipated to decline owing to a majority of the women working from home, enabling them to devote more time towards breastfeeding their infants. However, hospitals and clinics are poised to leverage demand for the pumps, owing to rising precautionary measures being implemented in such settings to stem the spread of the COVID-19 infection. One of these practices includes extracting breast milk through pumps and then feeding it to the infants.

For comprehensive insights on this market adoption, ask an analyst here-

https://www.factmr.com/connectus/sample?flag=AE&rep_id=4690

Global Breast Pumps Market Segmentation

Fact.MR has studied the global breast pumps market with detailed segmentation on the basis of product, application and regions.

Product Application Region
Single Electric Breast Pumps Hospital Grade North America
Double Electric Breast Pumps Personal Use Europe
Manual Breast Pumps Asia Pacific
Latin America
Middle East & Africa (MEA)

“This taxonomy prepared is confidential and intended exclusively for the individual or entity with whom it is being shared. Reading, disseminating, distributing, or copying this to any party other than addressee(s) is unauthorized and prohibited.”

High Purity Quartz Sand Industry Survey Report by Fact.MR –

https://www.youtube.com/watch?v=ItwHQrt-vmY

Global Breast Pumps Market Competition Structure:

The global breast pumps market consists of a large number of important market players. These are: Medela LLC, Pigeon Group, Koninklijke Philips N.V, Ameda, Inc., Ardo Medical AG, Evenflo Feeding, Inc. and Mayborn Group Limited (Shanghai Jahwa Co. Ltd.) to name a few. Educating consumers, entry into lucrative markets with new distribution networks and expanding direct and indirect sales activities are key strategies adopted by market players.

Medela LLC, the leading market player, relies on digital media to communicate directly with consumers. It’s MyMedela App provides assistance in meeting daily breastfeeding goals with personalized content, an activity tracker, pumping tips and interactive checklists. Besides this, it also manufactures the Harmony Manual Breast Pump and Sonata Smart Electric Breast Pump among others.

Another market leader, Pigeon Group, manufactures the Pigeon Manual Breast Pump with Glass Shield, the Pigeon C Type Silent Electric Breast Pump and Lansinoh Smart pump Double Electric Breast Pump. It also conducted maternity seminars in 2016 to spread awareness about the importance of breastfeeding to working women.

For More Insights:

https://www.biospace.com/article/ambulatory-infusion-offerings-gain-ground-for-emergency-applications-in-the-parenteral-feeding-devices-market-fact-mr

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

Circulating Tumor Cell (CTC) Test Biomarkers Market: North America Accounts for More than 2/5th Market Share : Fact.MR

Manual storage systems are projected to register 64% share in the biobanking market by 2027, given their low capital requisites. However, players in the biobanking market are increasingly striving to transform the landscape through the introduction of advanced software, which helps in reducing manual errors. Automated storage systems offer high precision and time-efficiency, which is likely to significantly increase their adoption in the foreseeable future. Automated storage systems are projected to register a CAGR of 7% during the forecast period (2020-2027).

For More Insights Into The Market, Request a Sample of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=250

A senior research analyst at Fact.MR opines, “Though the application of biospecimen for the development of therapeutics is growing, there will be a notable spurt in the adoption rate of bio-samples for clinical diagnosis to understand cell structure.”

Key Highlights of Biobanking Market Study

  • China shows strong growth prospects in the biobanking market with an estimated CAGR of around 8.6% during 2020-2027. The country has three biobanks – China Kadoorie Biobank, Zhongnan Biobank, and Cancer Centre Tissue Bank, which work towards investigating the genetic causes of infectious and chronic diseases.
  • Demand for biobanking software and services is growing at a relatively high rate as compared to equipment and consumables, as these products are used to minimise errors and increase the accuracy of sample data. Biobanking software and services are projected to be deployed at the highest CAGR of around 7.5% in the biobanking market during the forecast period.
  • Blood products are expected to remain key biospecimen in the biobanking market, exceeding the storage of other samples, as demand for blood transfusion and DNA is increasing for the diagnosis and treatment of chronic diseases.
  • The set-up cost of a biobank can vary from US$ 3 Mn to US$ 6 Mn. Sample handling, storage management, human resources, instruments, consumables, and software further add up to the already high cost of biobanking, which is likely to act as a barrier to the growth of the biobanking market.

Access Research Methodology Prepared By Experts – https://www.factmr.com/connectus/sample?flag=RM&rep_id=250

Biobanking Market – Assessment of Key Segments

Storage
  • Manual
  • Automated
Application
  • Therapeutics
  • Clinical Diagnostics
  • Drug Discovery & Development
  • Others
Biospecimen
  • Blood Products
  • Human Tissues
  • Cell Lines
  • Nucleic Acids
  • Others
Product
  • Equipment
    • Temperature Control Systems
      • Freezers & Refrigerators
      • Cryogenic Storage Systems
      • Thawing Equipment
  • Incubators & Centrifuges
  • Alarms & Monitoring Systems
  • Accessories & Other Equipment
  • Consumables
    • Cryovialsand Cryomolds
    • Tubes
    • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

High Purity Quartz Sand Industry Survey Report by Fact.MR –

https://www.youtube.com/watch?v=ItwHQrt-vmY

Following Questions Answers Covered in the Report are:

  • How will the global Biobanking Equipment Market perform during the forecast period? What will be the market size in terms of value and volume?
  • Which segment will drive the global Biobanking Equipment Market? Which regional market will show extensive growth in the future? What are the reasons?
  • How will the market dynamics change because of the impact of future market opportunities, restraints, and drivers?
  • What are the key strategies adopted by players to sustain themselves in the global Biobanking Equipment Market?
  • How will these strategies influence the market growth and competition?

Key players operating in the biobanking market

  • Thermo Fisher Scientific Inc.
  • Tecan Trading AG
  • PHC Holdings Corporation (Panasonic Healthcare)
  • Merck KGaA
  • Hamilton Company
  • Brooks Automation, Inc.
  • Chart Industries, Inc.
  • Greiner AG
  • VWR International, LLC
  • QIAGEN N.V.

Get More Insights –http://www.globenewswire.com/en/news-release/2019/03/04/1746055/0/en/US-3-Bn-Genealogy-Products-and-Services-Market-Driven-by-Surging-Demand-for-DNA-Testing-Fact-MR-Study.html

The Report Covers Exhaustive Analysis On:

  • Market Segments
  • Market Dynamics
  • Market Size & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Share Your Requirements & Get Customized Reports – https://www.factmr.com/connectus/sample?flag=RC&rep_id=250

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

Growing Trend of Personalised Medicines Fuels The Demand for Automated Storage Systems In Biobanking

Manual storage systems are projected to register 64% share in the biobanking market by 2027, given their low capital requisites. However, players in the biobanking market are increasingly striving to transform the landscape through the introduction of advanced software, which helps in reducing manual errors. Automated storage systems offer high precision and time-efficiency, which is likely to significantly increase their adoption in the foreseeable future. Automated storage systems are projected to register a CAGR of 7% during the forecast period (2020-2027).

For More Insights Into The Market, Request a Sample of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=250

A senior research analyst at Fact.MR opines, “Though the application of biospecimen for the development of therapeutics is growing, there will be a notable spurt in the adoption rate of bio-samples for clinical diagnosis to understand cell structure.”

assessment of lucrative opportunities in biobanking market

Key Highlights of Biobanking Market Study

  • China shows strong growth prospects in the biobanking market with an estimated CAGR of around 8.6% during 2020-2027. The country has three biobanks – China Kadoorie Biobank, Zhongnan Biobank, and Cancer Centre Tissue Bank, which work towards investigating the genetic causes of infectious and chronic diseases.
  • Demand for biobanking software and services is growing at a relatively high rate as compared to equipment and consumables, as these products are used to minimise errors and increase the accuracy of sample data. Biobanking software and services are projected to be deployed at the highest CAGR of around 7.5% in the biobanking market during the forecast period.
  • Blood products are expected to remain key biospecimen in the biobanking market, exceeding the storage of other samples, as demand for blood transfusion and DNA is increasing for the diagnosis and treatment of chronic diseases.
  • The set-up cost of a biobank can vary from US$ 3 Mn to US$ 6 Mn. Sample handling, storage management, human resources, instruments, consumables, and software further add up to the already high cost of biobanking, which is likely to act as a barrier to the growth of the biobanking market.

Access Research Methodology Prepared By Experts – https://www.factmr.com/connectus/sample?flag=RM&rep_id=250

Biobanking Market – Assessment of Key Segments

 

Storage
  • Manual
  • Automated
Application
  • Therapeutics
  • Clinical Diagnostics
  • Drug Discovery & Development
  • Others
Biospecimen
  • Blood Products
  • Human Tissues
  • Cell Lines
  • Nucleic Acids
  • Others
Product
  • Equipment
    • Temperature Control Systems
      • Freezers & Refrigerators
      • Cryogenic Storage Systems
      • Thawing Equipment
  • Incubators & Centrifuges
  • Alarms & Monitoring Systems
  • Accessories & Other Equipment
  • Consumables
    • Cryovialsand Cryomolds
    • Tubes
    • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

High Purity Quartz Sand Industry Survey Report by Fact.MR –

https://www.youtube.com/watch?v=ItwHQrt-vmY

Following Questions Answers Covered in the Report are:

  • How will the global Biobanking Equipment Market perform during the forecast period? What will be the market size in terms of value and volume?
  • Which segment will drive the global Biobanking Equipment Market? Which regional market will show extensive growth in the future? What are the reasons?
  • How will the market dynamics change because of the impact of future market opportunities, restraints, and drivers?
  • What are the key strategies adopted by players to sustain themselves in the global Biobanking Equipment Market?
  • How will these strategies influence the market growth and competition?

Get More Insights –http://www.globenewswire.com/en/news-release/2019/03/04/1746055/0/en/US-3-Bn-Genealogy-Products-and-Services-Market-Driven-by-Surging-Demand-for-DNA-Testing-Fact-MR-Study.html

Key players operating in the biobanking market

  • Thermo Fisher Scientific Inc.
  • Tecan Trading AG
  • PHC Holdings Corporation (Panasonic Healthcare)
  • Merck KGaA
  • Hamilton Company
  • Brooks Automation, Inc.
  • Chart Industries, Inc.
  • Greiner AG
  • VWR International, LLC
  • QIAGEN N.V.

The Report Covers Exhaustive Analysis On:

  • Market Segments
  • Market Dynamics
  • Market Size & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Share Your Requirements & Get Customized Reports – https://www.factmr.com/connectus/sample?flag=RC&rep_id=250

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com